U.S. Markets open in 61 hrs, 8 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 47.15 09:52 AM EDT | |
|---|---|---|
| Day High | 48.77 03:57 PM EDT |
|
| Range | 1.62 |
| Volume | 974,777 | |
|---|---|---|
| 30-Day Avg Vol | 667,000 |
|
| Difference | 46.14% |
| Market Cap | 3.10 B | |
|---|---|---|
| Mkt Cap Chg | -17.89 M |
| Shares Out | 63.91 M | |
|---|---|---|
| % Shrs Traded | 1.52% | |
| 1yr EPS Est | 2.697 |
| 52-Wk Low | 31.431 11/21/08 | |
|---|---|---|
| 52-Wk High | 99.08 8/7/08 |
|
| Range | 67.65 |
| Prev Close | 48.78 7/1/09 | |
|---|---|---|
| Today's Open | 48.06 | |
| Change | -1.48% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.97 M |
| Revenue (LFY) | 1.82 B | |
|---|---|---|
| Earnings (LFY) | 196.76 M | |
| Earnings (MRQ) | 40.30 M | |
| Next Earn Est | 0.627 | |
| Next Earnings | 07/27/2009 |
|
| EPS (TTM) | 2.95 | |
| 1yr EPS Growth | -8.27% |
| P/E Ratio (TTM) | 16.44 | |
|---|---|---|
| P/E Ratio (Fwd) | 17.00 | |
| PEG Ratio | 1.10 | |
| Return on Equity | 17.20 | |
| Beta | 1.05 |
| Sector | Services | |
|---|---|---|
| Industry | Diversified Services |
above for more info
CNBC Video
Behind every great drug company stands a great contract research organization (CRO), and Covance is one of the biggest. Covance helps pharmaceutical and biotech companies develop new drugs, providing preclinical ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.627 7/27/09 | — — |
—
—
|
| Last Quarter | 0.614 3/31/09 | 0.63 3/31/09 |
0.016
Beat
|
| 2 Quarters Ago | 0.699 12/31/08 | 0.72 12/31/08 |
0.021
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 468.46 M | 1.83 B |
| Gross Profit | 119.90 M | 513.83 M |
| Operating Income | 55.94 M | 263.65 M |
| Net Income | 40.30 M | 196.76 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts